ProCE Banner Activity

Novel PrEP Modalities in Europe and Potential Barriers: Insights from HIVR4P 2024

Clinical Thought

Novel PrEP modalities in Europe, as well as potential barriers and facilitators of their implementation, are discussed by an expert following research findings highlighted at HIVR4P 2024.

Released: November 05, 2024

Expiration: November 04, 2025

Share

Faculty

Cristina Mussini

Cristina Mussini, MD

Full Professor of Infectious Diseases
Division of Infectious Diseases
University of Modena and Reggio Emilia
Modena, Italy

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Cristina Mussini, MD

Full Professor of Infectious Diseases
Division of Infectious Diseases
University of Modena and Reggio Emilia
Modena, Italy

Cristina Mussini, MD: consultant/advisor/speaker: Gilead, Johnson & Johnson, Merck Sharp & Dohme, ViiV.